Navigating the Impact of Trump’s Tariffs: Top 5 Industries in Focus

Analysis of New U.S. Tariffs on Canadian and Mexican Imports

In a significant policy development, President Donald Trump has announced an executive order instituting 25% tariffs on imports from Canada and Mexico, effective February 1, 2025. This action aligns with the administration’s “America First Trade Policy,” which seeks to bolster U.S. industries and employment by limiting imports from major trade partners. Previously, no specific 25% tariffs were imposed on these countries, though trade disputes and tariffs in other sectors were present, especially during Trump’s initial term. The tariffs appear to be part of a strategic initiative to renegotiate trade agreements and tackle trade imbalances. Among the key motivations for this decision are the enhancement of U.S. manufacturing and the rectification of trade deficits. Additionally, these tariffs are speculated to serve as a negotiating tool in ongoing trade discussions with Canada and Mexico.

In general, president Trump’s announcement of a 25% tariff on Canada and Mexico, effective February 1, 2025, is motivated by several strategic objectives:

• Addressing Illegal Immigration:The tariffs are intended to prompt Canada and Mexico to strengthen their border security measures as a response to the influx of undocumented migrants into the United States.
• Combating the Fentanyl Crisis:The initiative also targets the reduction of chemical smuggling used in the production of fentanyl, a synthetic opioid exacerbating the opioid crisis in the U.S.
• Reducing Trade Deficits:A key goal is to decrease the U.S. trade deficits with Canada and Mexico. The administration believes that these tariffs will enhance the competitiveness of American goods and contribute to more balanced trade relations.
• Utilizing Economic Leverage:The tariffs serve as a tool for negotiating improved trade agreements, encouraging Canada and Mexico to more effectively address the concerns of the United States.

 The success of these tariffs in meeting Trump’s goals is uncertain and may face significant challenges.

Data from theU.S. Census Bureauhighlights a persistent trade deficit with Canada, where import values have consistently overshadowed U.S. exports. As per January 2025 survey data, the U.S. total trade deficit expanded by 6.2%, reaching $78.2 billion in November 2024. Moreover, the trade deficit with Mexico escalated by $21.9 billion, amounting to $152.4 billion in 2023. At the same time the U.S. trade in goods with Canada has being continuously declining from 2022 and reached $55 billion by the end of 2024.

Source: U.S. Census Bureau, Ki-Wealth Research estimates

In 2023, exports to Latin America and the Other Western Hemisphere represented 23.2% of total U.S. exports, while imports from these regions comprised 20.5% of total U.S. imports. Industrial supplies and materials led U.S. exports to Latin America and the Other Western Hemisphere, accounting for 31.4% of exports, whereas automotive vehicles, parts, and engines were the predominant imports, constituting 22.5% of U.S. imports from these regions.

Source: U.S. Census Bureau, Ki-Wealth Research estimates

Impact of U.S.-Mexico-Canada Trade Dynamics and Impending Tariffs

As of late 2024, the trade dynamics between the United States, Canada, and Mexico were characterized by substantial volumes. The trade between the U.S. and Mexico reached approximately $1.5 trillion, accounting for 5.14% of the U.S. Gross Domestic Product (GDP), which stood at $29.18 trillion in 2024. In parallel, trade with Canada amounted to around $914.3 billion, representing 3.13% of the U.S. GDP.

When examining the U.S.’s total annual trading volume in goods, which was $5.8 trillion in 2024, the significance of Mexico and Canada’s contributions becomes evident. Mexico accounted for 25.86% of the U.S. trading volume, while Canada contributed 15.76%.

The introduction of 25% tariffs, scheduled to commence on February 1, 2025, is anticipated to have a profound impact on these trade volumes. The expected consequences include:

1. Increased Costs: The tariffs will elevate the prices of imported goods, diminishing their competitiveness.
2. Reduced Trade Flow: Higher costs are likely to suppress demand, leading to a contraction in trade volumes.
3. Economic Strain: The potential for economic deceleration in all three nations could further exacerbate the reduction in trade activities.

The Potential Impact of Tariffs on Key U.S.Industries

The imposition of tariffs is anticipated to have significant ramifications across several vital sectors in the United States. An analysis of five key industries reveals the following potential impacts:

1. Automotive Industry: The automotive sector heavily relies on the importation of car parts and vehicles from Canada and Mexico. Tariffs are expected to elevate production costs, which may consequently lead to increased prices for consumers.
2. Agriculture: The U.S. agricultural sector imports a substantial volume of products from neighboring countries. The introduction of tariffs could escalate the prices of food and agricultural goods, impacting both producers and consumers adversely.
3. Manufacturing: Many manufacturing industries depend on raw materials and components sourced from Canada and Mexico. The rise in costs due to tariffs could disrupt supply chains, potentially diminishing the sector’s competitiveness.
4. Retail: Retailers procuring goods from Canada and Mexico may encounter heightened costs, which could be transferred to consumers in the form of increased retail prices.
5. Healthcare:The healthcare industry is significantly reliant on medical supplies and pharmaceuticals imported from Canada and Mexico. Tariffs are likely to augment the costs of these essential goods, thereby increasing expenses for healthcare providers and possibly leading to higher costs for patients. Moreover, disruptions in supply chains for critical medical products could cause delays and shortages, impacting the availability of vital medications and medical devices.

Analyzing the Impact of Tariffs on U.S. Automotive Industry

The automotive industry in the United States is heavily reliant on imports from Mexico and Canada. Mexico plays a crucial role as a major exporter of vehicles to the U.S., including popular models such as the Chevy Silverado, GMC Sierra, and various SUVs. Additionally, critical components like engines and transmissions, along with essential electrical systems and parts necessary for vehicle assembly, are sourced from Mexico.

Similarly, Canada exports key vehicle models, including the Chevrolet Silverado Heavy Duty truck and electric vans, to the U.S. It also supplies vital components such as engines and transmissions, as well as steel and aluminum, which are critical to vehicle manufacturing.

In 2024, theU.S. imported approximately 3.6 million light vehicles from Canada and Mexico, accounting for22% of all vehicles sold in the country. Notably, General Motors alone imported around 750,000 vehicles from these two nations in the same year. The absence of imports for engines, transmissions, electrical systems, steel, and aluminum would lead to significant disruptions in the production processes of U.S. automotive manufacturers. The integrated supply chain between the U.S., Mexico, and Canada underscores the indispensability of these imports for the industry.

In response to the imposed tariffs, many U.S. auto manufacturers are seeking to adjust their supply chains. A survey conducted by theNorth American industrial sourcing platformrevealed that nearly 85% of respondents plan to increase business with North American suppliers, which includes adding new suppliers for products and raw materials. Innovations such as 3D printing, robotics, and AI integration are making domestic production of components more feasible. However, higher labor costs and a shortage of skilled labor present significant challenges to reshoring efforts.

Given these factors, the likelihood of a rapid shift is moderate. While there is a strong intention and some momentum towards reshoring, the challenges related to labor and costs may slow down the process. However, the ongoing investment in technology and the strategic focus on North American suppliers suggest a gradual but steady transition.

In summary, I expect U.S. auto manufacturers to experience short- and mid-term challenges due to reshoring efforts. The shift back to domestic production may increase costs, driven by higher labor expenses and necessary investments in new facilities and technologies. Consequently, profit margins for U.S. auto producers are likely to decrease in 2025. However, over time, reducing reliance on foreign suppliers could stabilize supply chains and potentially lower costs by cutting down on transportation expenses.

The reshoring of the U.S. automotive supply chain in 2025 is likely to impact several major automakers, particularly those with significant operations in North America. Here are some of the most affected:

General Motors (GM)

• Impact: GM has extensive manufacturing operations in both Mexico and Canada. The shift to domestic sourcing will require significant adjustments in their supply chain management.
• Reshoring Efforts: GM is investing heavily in North American suppliers and advanced manufacturing technologies to mitigate the impact.

Ford Motor Company(F)

• Impact: Ford relies on a substantial amount of components and vehicles from Mexico and Canada. The reshoring efforts will affect their production costs and logistics.
• Reshoring Efforts: Ford is focusing on increasing its domestic production capabilities and investing in new technologies to streamline operations.

Stellantis(STLA)

• Impact: Stellantis, which includes brands like Chrysler, Dodge, and Jeep, also has significant dependencies on imports from Mexico and Canada.
• Reshoring Efforts: Stellantis is working on enhancing its U.S. manufacturing footprint and sourcing more parts locally.

Tesla(TSLA)

• Impact: While Tesla has a strong domestic manufacturing base, it still relies on some imported components. The reshoring trend will push Tesla to further localize its supply chain.
• Reshoring Efforts: Tesla is investing in domestic battery production and other key components to reduce dependency on foreign suppliers.

Analyzing the Impact of Tariffs on U.S. Agriculture

In 2024, the United States’ agricultural sector experienced notable import activity from Canada and Mexico. Significant quantities of beef and seafood were imported from Canada, along with key vegetables such as potatoes and onions. Although there was a trade surplus in grains and oilseeds, these commodities still constituted an important component of imports.

From Mexico, the U.S. imported major quantities of tomatoes, avocados, strawberries, raspberries, and bell peppers. Furthermore, beer and tequila were also significant imports. There was a marked increase in the importation of other agricultural products, including chocolate, coffee, and frozen orange juice.

The imported beef, seafood, potatoes, and onions from Canada are critical due to high demand and the existing trade deficit in these categories. Similarly, the importation of tomatoes, avocados, and berries from Mexico is crucial given their substantial share in U.S. imports and the dependency on Mexico for these fresh produce items.

With the imposition of 25% tariffs, there is an anticipated positive impact on U.S. agriculture. Domestic farmers often face intense competition from imported goods, which can suppress prices and reduce profit margins. The introduction of tariffs is expected to increase demand for domestically produced beef, potatoes, onions, tomatoes, and other products, potentially driving up food prices. However, reduced competition could enhance the profitability of U.S. agricultural enterprises and benefit domestic farmers. While imports are vital for satisfying consumer demand and ensuring market stability, they also present competitive challenges for U.S. farmers.

On the downside, it is unlikely that U.S. farmers and agricultural companies will be able to entirely substitute the imported volume of food. Certain products, such as avocados and tomatoes, are suited to specific climates that cannot be easily replicated within the U.S. Additionally, domestic farmers may lack the infrastructure and resources necessary to quickly scale up production to replace imports. The cost of producing some agricultural goods domestically can be higher than importing them, making it economically challenging for U.S. farmers to compete.

Overall, the potential outcome could be an increase in food prices, contributing to rising inflation in the medium term.

Analyzing the Impact of Tariffs on U.S. Manufacturing

In 2024, approximately 28% of all U.S. imports, equating to around $844 billion, originated from Canada and Mexico. Notably, imports of electronic computers from these countries reached $39 billion. The U.S. manufacturing industry also relied heavily on steel and aluminum imports from Canada and Mexico. Specifically, the U.S. imported approximately 3.6 million metric tons of steel from Mexico, making it the largest steel exporter to the U.S., followed by Canada with about 2.8 million metric tons. While precise figures for aluminum imports from these countries in 2024 are unavailable, Canada has traditionally served as a key aluminum supplier to the U.S., owing to its strong aluminum industry. It is estimated that tariffs on steel, aluminum, and derivative goods currently account for$2.63 billion of the $79 billion in tariffs,based on initial import values. These imports are vital for various industries, including automotive, construction, and aerospace, facilitating the seamless functioning of U.S. manufacturing processes.

The Critical Manufacturing Sector is essential to the economic prosperity and continuity of the United States. A direct attack or disruption of certain elements within the manufacturing industry could hinder essential functions at the national level and impact multiple critical infrastructure sectors. This sector has dependencies and interdependencies with a wide range of other sectors, such as:

• Transportation Systems: The Critical Manufacturing Sector depends on the Transportation Systems Sector for shipping goods and materials, while also producing the ships, aircraft, and trucks necessary for their movement.
• Energy: The sector relies on energy to operate facilities and produces turbines, switchgear, transformers, and electric motors.
• Chemical: It requires chemicals for processing unrefined ore and treating processed metals and metal products, in addition to producing air and gas compressors and nonagricultural spraying and dusting equipment.
• Water: The sector utilizes water for its operations and manufactures iron pipes, valves, and compressors for water movement.

Many U.S. manufacturers depend on components and materials from Canada and Mexico. Tariffs can disrupt these supply chains, leading to delays and increased costs, potentially making U.S. products less competitive in the global market and resulting in reduced sales and job losses.

Considering the extensive scope of the U.S. critical manufacturing sector, it is estimated that the U.S. economy could contract by 0.4% year-over-year, potentially resulting in the loss of approximately 142,000 full-time jobs. However, these adverse effects are expected to be short- to mid-term. In the long term, much will depend on U.S. energy policy. As Donald Trump relaxes regulations for oil and gas mining companies, the reduced energy costs in the U.S. could partially mitigate the rising costs of manufacturing supply materials and labor.

Who Benefits from the U.S. 25% Tariffs on Canadian and Mexican Goods?

Analyzing the Impact of Tariffs on U.S. Healthcare

Fentanyl,a synthetic opioid, is primarily utilized for pain management in medical settings, particularly in cases of severe pain such as that experienced by cancer patients or individuals recovering from surgery. Its potency is significantly higher than that of morphine, ranging from 50 to 100 times more powerful. Fentanyl operates by binding to opioid receptors in the brain, thereby alleviating pain and inducing sensations of relaxation and euphoria.

In thehealthcare industry, fentanyl is administered in various forms, including patches, lozenges, and injections. However, its illicit production and distribution have considerably exacerbated the opioid crisis.In 2024, the United States seized approximately 16,565 pounds of fentanylat its borders between January and September. A substantial portion of this was intercepted at official ports of entry, predominantly along the southwest border with Mexico, while seizures at the northern border with Canada were comparatively minimal.

The precise volume of fentanyl legally imported for medical purposes is not typically disclosed in public reports. However, the emphasis on seizures underscores the persistent challenge of illicit fentanyl trafficking. The imposition of 25% tariffs on goods from Mexico and Canada is designed to encourage these countries to intensify efforts against illegal drug trafficking, including fentanyl. Nevertheless, these tariffs may have several implications:

1. Supply Chain Disruption: The tariffs could disrupt supply chains for legitimate pharmaceutical ingredients, potentially complicating access to essential medications for healthcare providers.
2. Increased Costs: Higher tariffs could escalate costs for pharmaceutical companies, potentially resulting in increased drug prices for consumers.
3. Illicit Trade: While the tariffs aim to deter illegal drug trafficking, their impact on the clandestine and complex supply chains of illicit fentanyl remains uncertain.

The imposition of tariffs poses significant challenges for the U.S. healthcare sector, with potential implications as follows:

1. Escalating Medication Costs:The increased expense of importing pharmaceutical components is likely to drive up medication prices, impacting both patients and healthcare providers adversely.
2. Supply Chain Disruptions:Interruptions in the supply chain may result in shortages of critical medications, complicating treatment protocols for patients suffering from severe pain and other conditions.
3. Intensified Economic Strain:Already grappling with inflation and labor shortages, the healthcare industry might face heightened financial pressures due to these additional tariff-related costs.

To navigate this evolving economic landscape, healthcare companies may explore alternative suppliers from non-tariff-affected countries to alleviate cost burdens. There is also a potential shift towards increased domestic production of medical products to minimize import dependency.

Healthcare providers are expected to enforce stricter cost management strategies to cope with rising expenses. Furthermore, industry associations may advocate for tariff exemptions or reductions on essential medical goods to mitigate adverse effects.

President Trump has implemented a series of measures designed to enhance the competitiveness of domestic healthcare companies. Key actions include:

• Revocation of Prior Policies: The administration has rescinded several executive orders from the Biden era, particularly those concerning drug pricing and the Affordable Care Act (ACA). This strategy aims to alleviate regulatory constraints on healthcare firms.
• Enhancement of Domestic Manufacturing:There is a pronounced focus on bolstering domestic production of medical supplies and pharmaceuticals. This initiative provides incentives for companies to increase manufacturing within the United States, thereby reducing dependency on imports.
• Regulatory Reforms:The administration has introduced regulatory reforms to expedite the approval processes for new medical products and technologies. These changes are intended to promote innovation while decreasing the time and expense associated with market entry for new products.
• Tax Incentives:Recently proposed tax incentives are aimed at stimulating investment in the healthcare sector, particularly for companies that focus on research and development or expand their manufacturing capacities domestically.

In our projections for the growth of the U.S. healthcare industry, we account for both the burden of tariffs and Trump’s incentive measures. We foresee only a short-to-medium-term negative impact from the 25% tariffs. However, in the long run, many healthcare companies may see improved profitability due to increased demand and rising prices for pharmaceuticals. Nonetheless, a significant concern remains the potential for prolonged inflationary pressures.

These Services are Coming Soon:

Unmatched Stock Insights

Proprietary Portfolio Strategies

Exclusive Crypto Breakdowns

STAY TUNED WITH US!